Clinical Trials Browser

Phase 2 × Carcinoma, Renal Cell × Panobinostat × Clear all

NCT00550277 2021-11-23

LBH589 Treatment for Refractory Clear Cell Renal Carcinoma

Phase 2 Completed

20 enrolled 7 charts

Carcinoma, Renal Cell